Boston Scientific (BSX) Tops Q2 EPS by 1c, Beats on Revenues; Boosts FY17 Revenue Guide Above Consensus & Raises FY17 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Boston Scientific (NYSE: BSX) | Delayed: 46.03 +2.53 (5.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.50 | 52 Week High | $24.79 | |||
| Open | $44.81 | 52 Week Low | $15.67 | |||
| Day High | $46.97 | P/E | N/A | |||
| Day Low | $44.76 | EPS | $-0.09 | |||
| Volume | 22,513,625 | |||||
